These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36204527)

  • 1. A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives.
    Ahmed J; Modica de Mohac L; Mackey TK; Raimi-Abraham BT
    J Med Access; 2022; 6():23992026221074548. PubMed ID: 36204527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A narrative review of illegal online pharmacies and contemporary issues with restricting FDA-approved medication access.
    Jillani Z; Reinhard L; Hertig J
    J Med Access; 2023; 7():27550834231220512. PubMed ID: 38149839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health, Economic, and Social Impacts of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review of Methodological Approaches.
    Salami RK; Valente de Almeida S; Gheorghe A; Njenga S; Silva W; Hauck K
    Am J Trop Med Hyg; 2023 Aug; 109(2):228-240. PubMed ID: 37339762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substandard and Falsified Medicines in Myanmar.
    Sakuda M; Yoshida N; Takaoka T; Sanada T; Rahman MS; Tanimoto T; Zin T; Kimura K; Tsuboi H
    Pharmacy (Basel); 2020 Mar; 8(1):. PubMed ID: 32204459
    [No Abstract]   [Full Text] [Related]  

  • 6. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review.
    Asrade Mekonnen B; Getie Yizengaw M; Chanie Worku M
    J Pharm Policy Pract; 2024; 17(1):2375267. PubMed ID: 39015754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substandard and falsified medical products are a global public health threat. A pilot survey of awareness among physicians in Sweden.
    Funestrand H; Liu R; Lundin S; Troein M
    J Public Health (Oxf); 2019 Mar; 41(1):e95-e102. PubMed ID: 29860331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I (Don't) want to consume counterfeit medicines: exploratory study on the antecedents of consumer attitudes toward counterfeit medicines.
    Ofori-Parku SS; Park SE
    BMC Public Health; 2022 Jun; 22(1):1094. PubMed ID: 35650557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research on the Development of Methods for Detection of Substandard and Falsified Medicines by Clarifying Their Pharmaceutical Characteristics Using Modern Technology.
    Yoshida N
    Biol Pharm Bull; 2024; 47(5):878-885. PubMed ID: 38692863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point-of-Care Anti-Counterfeit Medicines Technologies: Awareness and Utilization among Medical Practitioners in Eastern Nigeria.
    Iloh GU; Akodu BA; Emeka EA; Obi IV
    West Afr J Med; 2021 Nov; Vol. 38(11):1029-1035. PubMed ID: 34918894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    Ozawa S; Evans DR; Bessias S; Haynie DG; Yemeke TT; Laing SK; Herrington JE
    JAMA Netw Open; 2018 Aug; 1(4):e181662. PubMed ID: 30646106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The era of fake medicines: Investigating counterfeit medicinal products for erectile dysfunction disguised asherbal supplements.
    Ho HMK; Xiong Z; Wong HY; Buanz A
    Int J Pharm; 2022 Apr; 617():121592. PubMed ID: 35182703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public Perception toward E-commerce of Medicines and Comparative Pharmaceutical Quality Assessment Study of Two Different Products of Furosemide Tablets from Community and Illicit Online Pharmacies.
    Ashames A; Bhandare R; Zain AlAbdin S; Alhalabi T; Jassem F
    J Pharm Bioallied Sci; 2019; 11(3):284-291. PubMed ID: 31555036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the Health and Economic Impact of Substandard and Falsified Medicines: A Review of Existing Models and Approaches.
    Ozawa S; Higgins CR; Nwokike JI; Phanouvong S
    Am J Trop Med Hyg; 2022 Jul; 107(1):14-20. PubMed ID: 35895357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: a retrospective review of data from the regulatory authority.
    Mori AT; Meena E; Kaale EA
    BMJ Open; 2018 Jun; 8(6):e021825. PubMed ID: 29950474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales.
    Liang BA; Mackey T
    Am J Law Med; 2009; 35(1):125-84. PubMed ID: 19534258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Illicit Internet availability of drugs subject to recall and patient safety consequences.
    Mackey TK; Aung P; Liang BA
    Int J Clin Pharm; 2015 Dec; 37(6):1076-85. PubMed ID: 26148859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.